These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23047844)

  • 1. 'He was like a zombie': off-label prescription of antipsychotic drugs in dementia.
    Harding R; Peel E
    Med Law Rev; 2013 Mar; 21(2):243-77. PubMed ID: 23047844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Off-Label Antipsychotic Medication Use in a Randomly Selected Nursing Home Sample Based on Resident and Facility Characteristics.
    Mansbach WE; Mace RA; Clark KM; Firth IM; Breeden JK
    Res Gerontol Nurs; 2016 Nov; 9(6):257-266. PubMed ID: 27665755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing Off-Label Antipsychotic Use in Older Community-Dwelling Adults With Dementia: A Narrative Review.
    Bain KT; Schwartz EJ; Chan-Ting R
    J Am Osteopath Assoc; 2017 Jul; 117(7):441-450. PubMed ID: 28662557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotics for BPSD: an audit of prescribing practice in a specialist psychiatric inpatient unit.
    Haw C; Stubbs J; Yorston G
    Int Psychogeriatr; 2008 Aug; 20(4):790-9. PubMed ID: 18307825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caregiver Perspectives About Using Antipsychotics and Other Medications for Symptoms of Dementia.
    Kerns JW; Winter JD; Winter KM; Kerns CC; Etz RS
    Gerontologist; 2018 Mar; 58(2):e35-e45. PubMed ID: 28402533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of behavioural and psychiatric symptoms in dementia: implications of recent safety warnings.
    Bullock R
    Curr Med Res Opin; 2005 Jan; 21(1):1-10. PubMed ID: 15881470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A risk-benefit assessment of risperidone for the treatment of behavioural and psychological symptoms in dementia.
    Zaudig M
    Drug Saf; 2000 Sep; 23(3):183-95. PubMed ID: 11005702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Care Physician Perspectives about Antipsychotics and Other Medications for Symptoms of Dementia.
    Kerns JW; Winter JD; Winter KM; Boyd T; Etz RS
    J Am Board Fam Med; 2018; 31(1):9-21. PubMed ID: 29330235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicians' reasons not to discontinue long-term used off-label antipsychotic drugs in people with intellectual disability.
    de Kuijper GM; Hoekstra PJ
    J Intellect Disabil Res; 2017 Oct; 61(10):899-908. PubMed ID: 28560761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotics for behavioural and psychological problems in elderly people with dementia: a systematic review of adverse events.
    van Iersel MB; Zuidema SU; Koopmans RT; Verhey FR; Olde Rikkert MG
    Drugs Aging; 2005; 22(10):845-58. PubMed ID: 16245958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Off-label use of antipsychotic medications in the department of Veterans Affairs health care system.
    Leslie DL; Mohamed S; Rosenheck RA
    Psychiatr Serv; 2009 Sep; 60(9):1175-81. PubMed ID: 19723731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis.
    Maher AR; Maglione M; Bagley S; Suttorp M; Hu JH; Ewing B; Wang Z; Timmer M; Sultzer D; Shekelle PG
    JAMA; 2011 Sep; 306(12):1359-69. PubMed ID: 21954480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use and safety of antipsychotics in behavioral disorders in elderly people with dementia.
    Gareri P; De Fazio P; Manfredi VG; De Sarro G
    J Clin Psychopharmacol; 2014 Feb; 34(1):109-23. PubMed ID: 24158020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic drug use and favourable natures of emotional functions in patients with dementia.
    Fujii M; Butler JP; Sasaki H
    Psychogeriatrics; 2019 Jul; 19(4):320-324. PubMed ID: 30784147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Off-label use of second-generation antipsychotic agents among elderly nursing home residents.
    Kamble P; Sherer J; Chen H; Aparasu R
    Psychiatr Serv; 2010 Feb; 61(2):130-6. PubMed ID: 20123817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of non-cognitive symptoms associated with dementia.
    Drug Ther Bull; 2014 Oct; 52(10):114-8. PubMed ID: 25298119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Off-label use of atypical antipsychotic medications in Canterbury, New Zealand.
    Monasterio E; McKean A
    N Z Med J; 2011 Jun; 124(1336):24-9. PubMed ID: 21946741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Audit of antipsychotic prescribing in dementia: Cambridgeshire results and lessons learnt.
    Wightman R; Fielding J; Green S
    Psychiatr Danub; 2011 Sep; 23 Suppl 1():S126-9. PubMed ID: 21894119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Halting Antipsychotic Use in Long-Term care (HALT): a single-arm longitudinal study aiming to reduce inappropriate antipsychotic use in long-term care residents with behavioral and psychological symptoms of dementia.
    Jessop T; Harrison F; Cations M; Draper B; Chenoweth L; Hilmer S; Westbury J; Low LF; Heffernan M; Sachdev P; Close J; Blennerhassett J; Marinkovich M; Shell A; Brodaty H
    Int Psychogeriatr; 2017 Aug; 29(8):1391-1403. PubMed ID: 28266282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.